These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 7657564)

  • 1. Cellular and antibody responses to equine herpesviruses 1 and 4.
    Studdert MJ
    J Am Vet Med Assoc; 1995 Sep; 207(6):698-701. PubMed ID: 7657564
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
    Fitzpatrick DR; Studdert MJ
    Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equine rhinopneumonitis vaccine: immunogenicity and safety in foals.
    Purdy CW; Porter RC; Ford SJ
    Am J Vet Res; 1978 May; 39(5):745-52. PubMed ID: 215062
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune escape of equine herpesvirus 1 and other herpesviruses of veterinary importance.
    van der Meulen KM; Favoreel HW; Pensaert MB; Nauwynck HJ
    Vet Immunol Immunopathol; 2006 May; 111(1-2):31-40. PubMed ID: 16472872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One way protection between equid herpesvirus 1 and 4 in vivo.
    Edington N; Bridges CG
    Res Vet Sci; 1990 Mar; 48(2):235-9. PubMed ID: 2159176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro stimulation of foal lymphocytes with equid herpesvirus 1.
    Thomson GR; Mumford JA
    Res Vet Sci; 1977 May; 22(3):347-52. PubMed ID: 195321
    [No Abstract]   [Full Text] [Related]  

  • 9. ADCC and complement-dependent lysis as immune mechanisms against EHV-1 infection in the horse.
    Stokes A; Wardley RC
    Res Vet Sci; 1988 May; 44(3):295-302. PubMed ID: 2841731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: Efficacy of modified live-virus equine rhinopneumonitis vaccine.
    Stear RL; Bass EP; Beckenhauer WH
    Am J Vet Res; 1976 Mar; 37(3):349-51. PubMed ID: 176909
    [No Abstract]   [Full Text] [Related]  

  • 11. [Training of the immune system of foals against ERP virus infections by frequent vaccination with presently available commercial vaccines].
    Bürki F; Nowotny N; Rossmanith W; Pallan C; Möstl K
    Dtsch Tierarztl Wochenschr; 1989 Apr; 96(4):162-5. PubMed ID: 2540944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of the passive hemagglutination test to the study of equine rhinopneumonitis. II. Serologic study in horses].
    Berrios P; Ibarra L; Riquelme S
    Rev Latinoam Microbiol; 1986; 28(4):339-43. PubMed ID: 3035677
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of age and pregnancy on the antibody and cell-mediated immune responses of horses to equine herpesvirus 1.
    Gerber JD; Marron AE; Bass EP; Beckenhauer WH
    Can J Comp Med; 1977 Oct; 41(4):471-8. PubMed ID: 200320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity to equine herpesvirus type 1 (rhinopneumonitis): in vitro lymphocyte response.
    Wilks CR; Coggins L
    Am J Vet Res; 1976 May; 37(5):486-92. PubMed ID: 179451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccination against the paralytic form of EHV1?].
    Breukink HJ; Binkhorst GJ; van Oirschot JT
    Tijdschr Diergeneeskd; 1983 May; 108(9):359. PubMed ID: 6306862
    [No Abstract]   [Full Text] [Related]  

  • 16. [EHV1, to vaccinate or not?].
    Binkhorst GJ; van Oirschot JT; Breukink HJ
    Tijdschr Diergeneeskd; 1985 Mar; 110(5):189-90. PubMed ID: 2984805
    [No Abstract]   [Full Text] [Related]  

  • 17. Third International Havemeyer Workshop on Equine Herpesvirus type 1.
    Kydd JH; Slater J; Osterrieder N; Lunn DP; Antczak DF; Azab W; Balasuriya U; Barnett C; Brosnahan M; Cook C; Damiani A; Elton D; Frampton A; Gilkerson J; Goehring L; Horohov D; Maxwell L; Minke J; Morley P; Nauwynck H; Newton R; Perkins G; Pusterla N; Soboll-Hussey G; Traub-Dargatz J; Townsend H; Van de Walle GR; Wagner B
    Equine Vet J; 2012 Sep; 44(5):513-7. PubMed ID: 22888774
    [No Abstract]   [Full Text] [Related]  

  • 18. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 1 virus.
    Burrows R; Goodridge D; Denyer MS
    Vet Rec; 1984 Apr; 114(15):369-74. PubMed ID: 6328728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The equine immune response to equine herpesvirus-1: the virus and its vaccines.
    Kydd JH; Townsend HG; Hannant D
    Vet Immunol Immunopathol; 2006 May; 111(1-2):15-30. PubMed ID: 16476492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of a chemically inactivated, adjuvanted vaccine to control abortigenic infection of mares by equine herpesvirus I.
    Bryans JT; Allen GP
    Dev Biol Stand; 1982; 52():493-8. PubMed ID: 6299858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.